| Ident. | Authors (with country if any) | Title |
|---|
| 000931 (2013) |
Tony Velkov [Australie, États-Unis] | The specificity of the influenza B virus hemagglutinin receptor binding pocket: what does it bind to? |
| 000937 (2013) |
S. Yan [République populaire de Chine] ; G. Wu [République populaire de Chine] | Small Variations Between Species/Subtypes Attributed to Reassortment Evidenced from Polymerase Basic Protein 1 with Other Seven Proteins from Influenza A Virus |
| 000D13 (2011) |
Thomas Han [États-Unis] ; Wayne A. Marasco [États-Unis] | Structural basis of influenza virus neutralization |
| 000D31 (2011) |
Hans D. Klenk [Allemagne] ; Wolfgang Garten [Allemagne] ; Mikhail Matrosovich [Allemagne] | Molecular mechanisms of interspecies transmission and pathogenicity of influenza viruses: Lessons from the 2009 pandemic |
| 000D46 (2011) |
Karen Ka Yin Wong [Australie] ; Rowena A. Bull [Australie] ; Steve Rockman [Australie] ; Gillian Scott [Australie] ; Sacha Stelzer-Braid [Australie] ; William Rawlinson [Australie] | Correlation of polymerase replication fidelity with genetic evolution of influenza A/Fujian/411/02(H3N2) viruses |
| 000F57 (2010) |
S. Yan [République populaire de Chine] ; G. Wu [République populaire de Chine] | Evidence Obtained from anova to Reason Cross‐species Infection and Cross‐subtype Mutation in Neuraminidases of Influenza A Viruses |
| 000F60 (2010) |
Guillermo Ruiz-Carrascoso [Espagne] ; Inmaculada Casas [Espagne] ; Francisco Pozo [Espagne] ; Carmen Pérez-González [Espagne] ; Jordi Reina [Espagne] ; Pilar Pérez-Bre A [Espagne] | Development and implementation of influenza a virus subtyping and detection of genotypic resistance to neuraminidase inhibitors |
| 001180 (2009) |
Payel Das [États-Unis] ; Jingyuan Li [États-Unis] ; Ajay K. Royyuru [États-Unis] ; Ruhong Zhou [États-Unis] | Free energy simulations reveal a double mutant avian H5N1 virus hemagglutinin with altered receptor binding specificity |
| 001182 (2009) |
Harald Brüssow [Suisse] | Europe, the bull and the Minotaur: the biological legacy of a Neolithic love story |
| 001340 (2008) |
Samson S. Y. Wong [Hong Kong] ; Kwok-Yung Yuen [Hong Kong] | Antiviral therapy for respiratory tract infections |
| 001555 (2006) |
Alan W. Hampson [Australie] | Avian influenza: A pandemic waiting in the wings? |
| 001612 (2005) |
Penelope Ward [Royaume-Uni] ; Ian Small [Royaume-Uni] ; James Smith [Suisse] ; Pia Suter [Suisse] ; Regina Dutkowski [États-Unis] | Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic |
| 001634 (2005) |
Derrick Louz [Pays-Bas] ; Hans E. Bergmans [Pays-Bas] ; Birgit P. Loos [Pays-Bas] ; Rob C. Hoeben [Pays-Bas] | Cross‐species transfer of viruses: implications for the use of viral vectors in biomedical research, gene therapy and as live‐virus vaccines |
| 001721 (2003) |
Mikhail Matrosovich [Allemagne, Russie] ; Hans-Dieter Klenk [Allemagne] | Natural and synthetic sialic acid‐containing inhibitors of influenza virus receptor binding |
| 001724 (2003) |
Susan J. Baigent [Royaume-Uni] ; John W. Mccauley [Royaume-Uni] | Influenza type A in humans, mammals and birds: Determinants of virus virulence, host‐range and interspecies transmission |
| 001774 (2002) |
Gabriele Neumann [États-Unis] ; Yoshihiro Kawaoka [États-Unis, Japon] | Generation of influenza A virus from cloned cDNAs — historical perspective and outlook for the new millenium |
| 001775 (2002) |
Ralf Wagner [Allemagne] ; Mikhail Matrosovich [Allemagne, Russie] ; Hans-Dieter Klenk [Allemagne] | Functional balance between haemagglutinin and neuraminidase in influenza virus infections |
| 001827 (2001) |
A. I. Klimov [États-Unis] ; I. V. Kiseleva [Russie] ; J. A. Desheva [Russie] ; G. I. Alexandrova [Russie] ; N. J. Cox [États-Unis] ; L. G. Rudenko [Russie] | Live attenuated reassortant influenza vaccine prepared using A/Leningrad/134/17/57 (H2N2) donor strain is genetically stable after replication in children 3-6 years of age |
| 001829 (2001) |
M. Louise Herlocher [États-Unis] ; Rob Fenton [Royaume-Uni] ; Andrew Merry [États-Unis] ; Stephanie Elias [États-Unis] ; Arnold S. Monto [États-Unis] | Influenza resistance to zanamivir generated in ferrets |
| 001837 (2001) |
A. I Klimov [États-Unis] ; I. V Kiseleva [Russie] ; G. I Alexandrova [Russie] ; N. J Cox [États-Unis] | Genes coding for polymerase proteins are essential for attenuation of the cold-adapted A/Leningrad/134/17/57 (H2N2) influenza virus |
| 001849 (2001) |
Jeffery K. Taubenberger [États-Unis] ; Ann H. Reid [États-Unis] ; Thomas A. Janczewski [États-Unis] ; Thomas G. Fanning [États-Unis] | Characterization of the 1918 influenza virus hemagglutinin and neuraminidase genes |
| 001856 (2001) |
Maria C. Zambon [Royaume-Uni] | The pathogenesis of influenza in humans |
| 001861 (2001) |
Ann H. Reid [États-Unis] ; Jeffery K. Taubenberger [États-Unis] ; Thomas G. Fanning [États-Unis] | The 1918 Spanish influenza:integrating history and biology |
| 001863 (2001) |
Gabriele Neumann [États-Unis] ; Yoshihiro Kawaoka [États-Unis] | Reverse Genetics of Influenza Virus |
| 001868 (2001) |
M. D Wareing [Australie] ; G. A Tannock [Australie] | Live attenuated vaccines against influenza; an historical review |
| 001878 (2001) |
Mikhail N. Matrosovich ; Scott Krauss ; Robert G. Webster | H9N2 Influenza A Viruses from Poultry in Asia Have Human Virus-like Receptor Specificity |
| 001882 (2001) |
Jeffery K. Taubenberger ; Scott P. Layne | Diagnosis of influenza virus: Coming to grips with the molecular era |
| 001884 (2001) |
Alexander C. Schmidt [États-Unis] ; Robert B. Couch [États-Unis] ; George J. Galasso [États-Unis] ; Frederick G. Hayden [États-Unis] ; John Mills [Australie] ; Brian R. Murphy [États-Unis] ; Robert M. Chanock [États-Unis] | Current research on respiratory viral infections: Third International Symposium |
| 001942 (2000) |
Margaret Tisdale [Royaume-Uni] | Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors |
| 001947 (2000) |
E. G. Brown [États-Unis] | Influenza virus genetics |
| 001951 (2000) |
Robert W. Sidwell [États-Unis] ; Donald F. Smee [États-Unis] | In vitro and in vivo assay systems for study of influenza virus inhibitors |
| 001953 (2000) |
Takahito Kashiwagi [Japon] ; Nobuyuki Hamada [Japon] ; Jun Iwahashi [Japon] ; Koyu Hara [Japon] ; Tatsuo Ueda [Japon] ; Hidetaro Noguchi [Japon] ; Tetsuya Toyoda [Japon] | Emergence of New Influenza A Viruses Which Carry an Escape Mutation of the HLA‐B27‐Restricted CTL Epitope of NP in Japan |
| 001963 (2000) |
Flor M. Munoz | Antiviral agents in the critically ill child |
| 001A16 (1999) |
David A. Steinhauer [Royaume-Uni] | Role of Hemagglutinin Cleavage for the Pathogenicity of Influenza Virus |
| 001A27 (1999) |
Masanori Terajima ; Julie Jameson ; Joyce E. Norman ; John Cruz ; Francis A. Ennis | High-Yield Reassortant Influenza Vaccine Production Virus Has a Mutation at an HLA-A 2.1-Restricted CD8+ CTL Epitope on the NS1 Protein |
| 001B01 (1998) |
Jane E. Bailly [Canada] ; Earl G. Brown [Canada] | Interference by a non-defective variant of influenza A virus is due to enhanced RNA synthesis and assembly |
| 001B02 (1998) |
K. A. Staschke [États-Unis] ; S. D. Hatch [États-Unis] ; J. C. Tang [États-Unis] ; W. J. Hornback [États-Unis] ; J. E. Munroe [États-Unis] ; J. M. Colacino [États-Unis] ; M. A. Muesing [États-Unis] | Inhibition of Influenza Virus Hemagglutinin-Mediated Membrane Fusion by a Compound Related to Podocarpic Acid |
| 001B04 (1998) |
C. Scholtissek [États-Unis] ; G. Quack [Allemagne] ; H. D Klenk [Allemagne] ; R. G Webster [États-Unis] | How to overcome resistance of influenza A viruses against adamantane derivatives |
| 001B18 (1998) |
Stephen S. Whitehead ; Cai-Yen Firestone ; Peter L. Collins ; Brian R. Murphy | A Single Nucleotide Substitution in the Transcription Start Signal of the M2 Gene of Respiratory Syncytial Virus Vaccine Candidate cpts 248/404 Is the Major Determinant of the Temperature-Sensitive and Attenuation Phenotypes |
| 001B30 (1997) |
Richard L. Hodinka | WHAT CLINICIANS NEED TO KNOW ABOUT ANTIVIRAL DRUGS AND VIRAL RESISTANCE |
| 001B45 (1997) |
Pierre Vialat [France] ; Rolf Muller [France] ; Thuy Hang Vu [France] ; Christophe Prehaud [France] ; Michèle Bouloy [France] | Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation |
| 001B50 (1997) |
M. García [États-Unis] ; D. L Suarez [États-Unis] ; J. M Crawford [États-Unis] ; J. W Latimer [États-Unis] ; R. D Slemons [États-Unis] ; D. E Swayne [États-Unis] ; M. L Perdue [États-Unis] | Evolution of H5 subtype avian influenza A viruses in North America |
| 001B53 (1997) |
T. M Sweet [États-Unis] ; H. F Maassab [États-Unis] ; K. Coelingh [États-Unis] ; M. L Herlocher [États-Unis] | Creation of amantadine resistant clones of influenza type A virus using a new transfection procedure |
| 001B55 (1997) |
Brian R. Murphy [États-Unis] ; Eun Ju Park [États-Unis] ; Paul Gottlieb [États-Unis] ; Kanta Subbarao [États-Unis] | An influenza A live attenuated reassortant virus possessing three temperature-sensitive mutations in the PB2 polymerase gene rapidly loses temperature sensitivity following replication in hamsters |
| 001B77 (1997) |
Hong Jin [États-Unis] ; George P. Leser [États-Unis] ; Jie Zhang [États-Unis] ; Robert A. Lamb [États-Unis] | Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape |
| 001B79 (1997) |
| In vitro activity of the neuraminidase inhibitor GS4071 against influenza viruses |
| 001B83 (1997) |
| GS 4104: A highly potent orally bioavailable influenza neuraminidase inhibitor |
| 001B91 (1997) |
| Characterization of influenza A viruses that are resistant to a fusion inhibitor related to podocarpic acid |
| 001B96 (1997) |
| A new class of carbocyclic influenza neuraminidase inhibitors: Structure-activity relationships |
| 001C13 (1996) |
M. Louise Herlocher [États-Unis] ; Anaira C. Clavo [États-Unis] ; Hunein F. Maassab [États-Unis] | Sequence comparisons of A/AA/6/60 influenza viruses: mutations which may contribute to attenuation |
| 001C25 (1996) |
Kurt P. Tolley [Royaume-Uni] ; Anthony C. Marriott [Royaume-Uni] ; Anna Simpson [Royaume-Uni] ; David J. Plows [Royaume-Uni, Grèce] ; David A. Matthews [Royaume-Uni, Canada] ; Sharon J. Longhurst [Royaume-Uni] ; Johanna E. Evans [Royaume-Uni] ; Jennifer L. Johnson [Royaume-Uni, États-Unis] ; Patricia A. Cane [Royaume-Uni] ; Valerie B. Randolph [États-Unis] ; Andrew J. Easton [Royaume-Uni] ; Craig R. Pringle [Royaume-Uni] | Identification of mutations contributing to the reduced virulence of a modified strain of respiratory syncytial virus |
